The case for plant-made veterinary immunotherapeutics

Biotechnology Advances

Volumn 34, Issue 5, 2016, Pages 597-604

  Topp, Edward ^a   Irwin, Rebecca ^b   McAllister, Tim ^c   Lessard, Martin ^d   Joensuu, Jussi J ^e   Kolotilin, Igor ^f   Conrad, Udo ^g   Stöger, Eva ^h   Mor, Tsafrir ⁱ   Warzecha, Heribert ^j   Hall, J Chris ^k   McLean, Michael D ^k   Cox, Eric ^l   Devriendt, Bert ^l   Potter, Andrew ^m   Depicker, Ann ^l   Virdi, Vikram ^l   Holbrook, Larry ⁿ   Doshi, Ketan ⁿ   Dussault, Marike ^o   Friendship, Robert ^p   Yarosh, Oksana ^q   Yoo, Han Sang ^r   MacDonald, Jacqueline ^a   Menassa, Rima ^a   more..

^a LONDON RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c LETHBRIDGE RESEARCH CENTRE   (Canada)

^d SHERBROOKE RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^e VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

^h UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

ⁱ ARIZONA STATE UNIVERSITY   (United States)

^j DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^k UNIVERSITY OF GUELPH   (Canada)

^l GHENT UNIVERSITY   (Belgium)

^m UNIVERSITY OF SASKATCHEWAN   (Canada)

ⁿ Box 19A RRNo5   (Canada)

^o ZOETIS   (United States)

^p UNIVERSITY OF GUELPH   (Canada)

^q CANADIAN FOOD INSPECTION AGENCY   (Canada)

^r Seoul National University   (South Korea)

more..

Author keywords

Antibiotic resistance; Antibody; Immunotherapeutic; Livestock production; Molecular farming; Plant biotechnology; Recombinant protein; Veterinary vaccine

Indexed keywords

AGRICULTURE; ANIMALS; ANTIBIOTICS; ANTIBODIES; BACTERIA; COST EFFECTIVENESS; DISEASE CONTROL; DISEASES; RECOMBINANT PROTEINS; VACCINES;

ANTIBIOTIC RESISTANCE; IMMUNOTHERAPEUTIC; LIVESTOCK PRODUCTION; MOLECULAR FARMING; PLANT BIOTECHNOLOGY; VETERINARY VACCINES;

INVESTMENTS;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; ANTIBODY; BACTERIUM; BIOTECHNOLOGY; COMPETITIVENESS; DEMAND ANALYSIS; INVESTMENT; LIVESTOCK FARMING; PLANT; PROTEIN; REGULATORY APPROACH; VACCINE;

ANIMALIA;

RECOMBINANT PROTEIN;

ANIMAL; ANIMAL DISEASE; BIOTECHNOLOGY; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; LIVESTOCK; METABOLISM; MOLECULAR FARMING; PLANT; VETERINARY MEDICINE;

ANIMAL DISEASES; ANIMALS; BIOTECHNOLOGY; IMMUNOTHERAPY; LIVESTOCK; MOLECULAR FARMING; PLANTS; RECOMBINANT PROTEINS; VETERINARY MEDICINE;

EID: 84958230932     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2016.02.007     Document Type: Review

References (114)

1. Aguirreburualde, M.S., Gomez, M.C., Ostachuk, A., Wolman, F., Albanesi, G., Pecora, A., et al. Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants. Vet. Immunol. Immunopathol. 151 (2013), 315–324.
2. Alvarez, M.L., Pinyerd, H.L., Topal, E., Cardineau, G.A., P19-dependent and P19-independent reversion of F1-V gene silencing in tomato. Plant Mol. Biol. 68 (2008), 61–79.
3. Alvarez, M.L., Topal, E., Martin, F., Cardineau, G.A., Higher accumulation of F1-V fusion recombinant protein in plants after induction of protein body formation. Plant Mol. Biol. 72 (2010), 75–89.
4. Anderson, J., Hagglund, S., Breard, E., Comtet, L., Lovgren Bengtsson, K., Pringle, J., et al. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle. Clin. Vaccine Immunol. 20 (2013), 1115–1122.
5. Anderson, J., Hagglund, S., Breard, E., Riou, M., Zohari, S., Comtet, L., et al. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle. Vaccine 32 (2014), 6614–6621.
6. Baldauf, K.J., Royal, J.M., Hamorsky, K.T., Matoba, N., Cholera toxin B: one subunit with many pharmaceutical applications. Toxins 7 (2015), 974–996.
7. Bhatla, S.C., Kaushik, V., Yadav, M.K., Use of oil bodies and oleosins in recombinant protein production and other biotechnological applications. Biotechnol. Adv. 28 (2010), 293–300.
8. Bock, R., Genetic engineering of the chloroplast: novel tools and new applications. Curr. Opin. Biotechnol. 26 (2014), 7–13.
9. Bock, R., Warzecha, H., Solar-powered factories for new vaccines and antibiotics. Trends Biotechnol. 28 (2010), 246–252.
10. Bosch, D., Castilho, A., Loos, A., Schots, A., Steinkellner, H., N-glycosylation of plant-produced recombinant proteins. Curr. Pharm. Des. 19 (2013), 5503–5512.
11. Caliber Biotherapeutics, http://www.caliberbio.com/ < accessed 2015/09/14 >, 2015.
12. Canadian Food Inspection Agency, Veterinary Biologics - Questions and Answers. http://www.inspection.gc.ca/animals/veterinary-biologics/licensed-products/frequently-asked-questions/eng/1318483540758/1320705655744 < accessed 2015/09/14 >, 2013.
13. Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jez, J., Gattinger, P., et al. In planta protein sialylation through overexpression of the respective mammalian pathway. J. Biol. Chem. 285 (2010), 15923–15930.
14. Castilho, A., Neumann, L., Daskalova, S., Mason, H.S., Steinkellner, H., Altmann, F., et al. Engineering of sialylated mucin-type O-glycosylation in plants. J. Biol. Chem. 287 (2012), 36518–36526.
15. Chan, H.T., Chia, M.Y., Pang, V.F., Jeng, C.R., Do, Y.Y., Huang, P.L., Oral immunogenicity of porcine reproductive and respiratory syndrome virus antigen expressed in transgenic banana. Plant Biotechnol. J. 11 (2013), 315–324.
16. Conley, A.J., Joensuu, J.J., Richman, A., Menassa, R., Protein body-inducing fusions for high-level production and purification of recombinant proteins in plants. Plant Biotechnol. J. 9 (2011), 419–433.
17. Cunha, C.E., Moreira, G.M., Salvarani, F.M., Neves, M.S., Lobato, F.C., Dellagostin, O.A., et al. Vaccination of cattle with a recombinant bivalent toxoid against botulism serotypes C and D. Vaccine 32 (2014), 214–216.
18. Czyz, M., Dembczynski, R., Marecik, R., Wojas-Turek, J., Milczarek, M., Pajtasz-Piasecka, E., et al. Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B. Biomed. Res. Int., 2014, 2014, 485689.
19. Deshpande, N., Jensen, P.H., Packer, N.H., Kolarich, D., GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. J. Proteome Res. 9 (2010), 1063–1075.
20. Devriendt, B., De Geest, B.G., Goddeeris, B.M., Cox, E., Crossing the barrier: targeting epithelial receptors for enhanced oral vaccine delivery. J. Control. Release 160 (2012), 431–439.
21. Dolcera, Veterinary vaccines market report. https://www.dolcera.com/wiki/index.php?title=Veterinary_Vaccines_Market_Report&oldid=11052 < accessed 2015/09/14 >, 2014.
22. Dou, W., Li, H., Cheng, Z., Zhao, P., Liu, J., Cui, Z., et al. Maternal antibody induced by recombinant gp85 protein vaccine adjuvanted with CpG-ODN protects against ALV-J early infection in chickens. Vaccine 31 (2013), 6144–6149.
23. Elson, C.O., Ealding, W., Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132 (1984), 2736–2741.
24. Fairbrother, J.M., Nadeau, E., Gyles, C.L., Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim. Health Res. Rev. 6 (2005), 17–39.
25. Fischer, R., Schillberg, S., Hellwig, S., Twyman, R.M., Drossard, J., GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol. Adv. 30 (2012), 434–439.
26. Floss, D.M., Falkenburg, D., Conrad, U., Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res. 16 (2007), 315–332.
27. Fraunhofer USA, http://www.fhcmb.org < accessed 2015/09/14 >, 2015.
28. G8 Science Ministers Statement, London UK, http://www.g8.utoronto.ca/science/130613-science.html < accessed 2015/09/14 >, 2013.
29. Gasdaska, J.R., Sherwood, S., Regan, J.T., Dickey, L.F., An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab. Mol. Immunol. 50 (2012), 134–141.
30. Glass-Kaastra, S.K., Pearl, D.L., Reid-Smith, R.J., McEwen, B., McEwen, S.A., Amezcua, R., et al. Describing antimicrobial use and reported treatment efficacy in Ontario swine using the Ontario swine veterinary-based surveillance program. BMC Vet. Res., 9, 2013, 238.
31. Gomez, E., Zoth, S.C., Berinstein, A., Plant-based vaccines for potential human application: a review. Hum Vaccin. 5 (2009), 738–744.
32. Gomord, V., Fitchette, A.C., Menu-Bouaouiche, L., Saint-Jore-Dupas, C., Plasson, C., Michaud, D., et al. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol. J. 8 (2010), 564–587.
33. Health for Animals, Global animal medicines association. Animal health industry global market review. http://healthforanimals.org/our-industry/animal-health-industry-global-market-review-2011/ < accessed 2015/09/14 >, 2014.
34. Hernandez, M., Rosas, G., Cervantes, J., Fragoso, G., Rosales-Mendoza, S., Sciutto, E., Transgenic plants: a 5-year update on oral antipathogen vaccine development. Expert Rev. Vaccines 13 (2014), 1523–1536.
35. Holmgren, J., Czerkinsky, C., Mucosal immunity and vaccines. Nat. Med. 11 (2005), S45–S53.
36. Hu, J., Ni, Y., Dryman, B.A., Meng, X.J., Zhang, C., Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV). Vaccine 30 (2012), 2068–2074.
37. Jin, S., Daniell, H., The engineered chloroplast genome just got smarter. Trends Plant Sci. 20 (2015), 622–640.
38. Joensuu, J.J., Verdonck, F., Ehrstrom, A., Peltola, M., Siljander-Rasi, H., Nuutila, A.M., et al. F4 (K88) fimbrial adhesin FaeG expressed in alfalfa reduces F4 + enterotoxigenic Escherichia coli excretion in weaned piglets. Vaccine 24 (2006), 2387–2394.
39. Kentucky Bioprocessing LLC, http://www.kbpllc.com/AboutUs.aspx < accessed 2015/09/14 >, 2015.
40. Khan, I., Twyman, R.M., Arcalis, E., Stoger, E., Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol. J. 7 (2012), 1099–1108.
41. Khandelwal, A., Lakshmi Sita, G., Shaila, M.S., Oral immunization of cattle with hemagglutinin protein of rinderpest virus expressed in transgenic peanut induces specific immune responses. Vaccine 21 (2003), 3282–3289.
42. Kim, M.C., Song, J.M.O.E., Kwon, Y.M., Lee, Y.J., Compans, R.W., et al. Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus. Mol. Ther. 21 (2013), 485–492.
43. Kolotilin, I., Kaldis, A., Devriendt, B., Joensuu, J., Cox, E., Menassa, R., Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco. PLoS ONE, 7, 2012, e42405.
44. Kolotilin, I., Topp, E., Cox, E., Devriendt, B., Conrad, U., Joensuu, J., et al. Plant-based solutions for veterinary immunotherapeutics and prophylactics. Vet. Res., 45, 2014, 117.
45. Kwon, K.C., Nityanandam, R., New, J.S., Daniell, H., Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells. Plant Biotechnol. J. 11 (2013), 77–86.
46. Kwon, K.C., Verma, D., Singh, N.D., Herzog, R., Daniell, H., Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv. Drug Deliv. Rev. 65 (2013), 782–799.
47. Lamphear, B.J., Jilka, J.M., Kesl, L., Welter, M., Howard, J.A., Streatfield, S.J., A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 22 (2004), 2420–2424.
48. Landry, N., Ward, B.J., Trepanier, S., Montomoli, E., Dargis, M., Lapini, G., et al. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS ONE, 5, 2010, e15559.
49. Le Mauff, F., Mercier, G., Chan, P., Burel, C., Vaudry, D., Bardor, M., et al. Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants. Plant Biotechnol. J. 13 (2015), 717–725.
50. Legisa, D.M., Perez Aguirreburualde, M.S., Gonzalez, F.N., Marin-Lopez, A., Ruiz, V., Wigdorovitz, A., et al. An experimental subunit vaccine based on bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, Guinea pigs and IFNAR(−/−) mice. Vaccine 33 (2015), 2614–2619.
51. Li, K., Gao, H., Gao, L., Qi, X., Gao, Y., Qin, L., et al. Recombinant gp90 protein expressed in Pichia pastoris induces a protective immune response against reticuloendotheliosis virus in chickens. Vaccine 30 (2012), 2273–2281.
52. Lin, G.J., Deng, M.C., Chen, Z.W., Liu, T.Y., Wu, C.W., Cheng, C.Y., et al. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission. Vaccine 30 (2012), 2336–2341.
53. Lycke, N., Lindholm, L., Holmgren, J., Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice. Clin. Exp. Immunol. 62 (1985), 39–47.
54. MacDonald, J., Doshi, K., Dussault, M., Hall, J.C., Holbrook, L., Jones, G., et al. Bringing plant-based veterinary vaccines to market: managing regulatory and commercial hurdles. Biotechnol. Adv, 2015.
55. Mapp Biopharmaceutical, http://www.mappbio.com/ < accessed 2015/09/14 >, 2015.
56. Mason, H.S., Herbst-Kralovetz, M.M., Plant-derived antigens as mucosal vaccines. Curr. Top. Microbiol. Immunol. 354 (2012), 101–120.
57. McGinnes, L.W., Pantua, H., Laliberte, J.P., Gravel, K.A., Jain, S., Morrison, T.G., Assembly and biological and immunological properties of Newcastle disease virus-like particles. J. Virol. 84 (2010), 4513–4523.
58. Medicago Inc., Product pipeline. http://www.medicago.com/English/Products/product-pipeline/default.aspx < accessed 2015/09/14 >, 2015.
59. Melkebeek, V., Goddeeris, B.M., Cox, E., ETEC vaccination in pigs. Vet. Immunol. Immunopathol. 152 (2013), 37–42.
60. Mignaqui, A.C., Ruiz, V., Perret, S., St-Laurent, G., Singh Chahal, P., Transfiguracion, J., et al. Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids. PLoS ONE, 8, 2013, e72800.
61. Miller, T., Fanton, M., Nickelson, S., Mason, H., Webb, S., Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutant Escherichia coli heat-labile toxin in chickens. Avian Pathol. 41 (2012), 441–449.
62. Mor, T.S., Molecular pharming's foot in the FDA's door: Protalix's trailblazing story. Biotechnol. Lett, 2015.
63. Niewold, T.A., van Dijk, A.J., Geenen, P.L., Roodink, H., Margry, R., van der Meulen, J., Dietary specific antibodies in spray-dried immune plasma prevent enterotoxigenic Escherichia coli F4 (ETEC) post weaning diarrhoea in piglets. Vet. Microbiol. 124 (2007), 362–369.
64. Nochi, T., Takagi, H., Yuki, Y., Yang, L., Masumura, T., Mejima, M., et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 10986–10991.
65. Pecora, A., Aguirreburualde, M.S., Aguirreburualde, A., Leunda, M.R., Odeon, A., Chiavenna, S., et al. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle. Vet. Res. Commun. 36 (2012), 157–164.
66. Pelosi, A., Piedrafita, D., De Guzman, G., Shepherd, R., Hamill, J.D., Meeusen, E., et al. The effect of plant tissue and vaccine formulation on the oral immunogenicity of a model plant-made antigen in sheep. PLoS ONE, 7, 2012, e52907.
67. Perez Filgueira, D.M., Zamorano, P.I., Dominguez, M.G., Taboga, O., Del Medico Zajac, M.P., Puntel, M., et al. Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity. Vaccine 21 (2003), 4201–4209.
68. Pradhan, S.N., Prince, P.R., Madhumathi, J., Roy, P., Narayanan, R.B., Antony, U., Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens. Vet. Immunol. Immunopathol. 148 (2012), 293–301.
69. Protalix Biotherapeutics, Development pipeline. http://www.protalix.com/development-pipeline/overview-development-pipeline.asp < accessed 2015/09/14 >, 2015.
70. Qi, Y., Kang, H., Zheng, X., Wang, H., Gao, Y., Yang, S., et al. Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs. Front. Microbiol., 6, 2015, 169.
71. Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J.B., et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514 (2014), 47–53.
72. Rosales-Mendoza, S., Salazar-Gonzalez, J.A., Immunological aspects of using plant cells as delivery vehicles for oral vaccines. Expert Rev. Vaccines 13 (2014), 737–749.
73. Rossi, L., Dell'Orto, V., Vagni, S., Sala, V., Reggi, S., Baldi, A., Protective effect of oral administration of transgenic tobacco seeds against verocytotoxic Escherichia coli strain in piglets. Vet. Res. Commun. 38 (2014), 39–49.
74. Salazar-Gonzalez, J.A., Banuelos-Hernandez, B., Rosales-Mendoza, S., Current status of viral expression systems in plants and perspectives for oral vaccines development. Plant Mol. Biol. 87 (2015), 203–217.
75. Scotti, N., Rybicki, E.P., Virus-like particles produced in plants as potential vaccines. Expert Rev. Vaccines. 12 (2013), 211–224.
76. Shen, H., Xue, C., Lv, L., Wang, W., Liu, Q., Liu, K., et al. Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease. Virus Res. 178 (2013), 430–436.
77. Sherman, A., Su, J., Lin, S., Wang, X., Herzog, R.W., Daniell, H., Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood 124 (2014), 1659–1668.
78. Snoeck, V., Peters, I.R., Cox, E., The IgA system: a comparison of structure and function in different species. Vet. Res. 37 (2006), 455–467.
79. Soria-Guerra, R.E., Moreno-Fierros, L., Rosales-Mendoza, S., Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches. Plant Cell Rep. 30 (2011), 1367–1382.
80. Steinkellner, H., Castilho, A., N-glyco-engineering in plants: update on strategies and major achievements. Methods Mol. Biol. 1321 (2015), 195–212.
81. Stoger, E., Fischer, R., Moloney, M., Ma, J.K., Plant molecular pharming for the treatment of chronic and infectious diseases. Annu. Rev. Plant Biol. 65 (2014), 743–768.
82. Strasser, R., Engineering of human-type O-glycosylation in Nicotiana benthamiana plants. Bioengineered 4 (2013), 191–196.
83. Takahashi, I., Marinaro, M., Kiyono, H., Jackson, R.J., Nakagawa, I., Fujihashi, K., et al. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J. Infect. Dis. 173 (1996), 627–635.
84. Thanavala, Y., Mahoney, M., Pal, S., Scott, A., Richter, L., Natarajan, N., et al. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 3378–3382.
85. The World Organisation for Animal Health, (OIE). Prevention and control of animal diseases worldwide. Economic Analysis — Prevention Versus Outbreak Costs. Final Report Part I, 2007 ( http://www.oie.int/doc/en_document.php?numrec=3552603 < accessed 2015/09/14 >).
86. Thuenemann, E.C., Meyers, A.E., Verwey, J., Rybicki, E.P., Lomonossoff, G.P., A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol. J. 11 (2013), 839–846.
87. Torrent, M., Llompart, B., Lasserre-Ramassamy, S., Llop-Tous, I., Bastida, M., Marzabal, P., et al. Eukaryotic protein production in designed storage organelles. BMC Biol., 7, 2009, 5.
88. UK Department of Health, UK Department for Environment, Food, Rural Affairs. UK Five Year Antimicrobial Resistance Strategy 2013 to 2018, 2013 ( https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf < accessed 2015/09/14 >).
89. Uribe-Campero, L., Monroy-Garcia, A., Duran-Meza, A.L., Villagrana-Escareno, M.V., Ruiz-Garcia, J., Hernandez, J., et al. Plant-based porcine reproductive and respiratory syndrome virus VLPs induce an immune response in mice. Res. Vet. Sci. 102 (2015), 59–66.
90. Van den Broeck, W., Cox, E., Goddeeris, B.M., Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect. Immun. 67 (1999), 520–526.
91. Van Molle, I., Joensuu, J.J., Buts, L., Panjikar, S., Kotiaho, M., Bouckaert, J., et al. Chloroplasts assemble the major subunit FaeG of Escherichia coli F4 (K88) fimbriae to strand-swapped dimers. J. Mol. Biol. 368 (2007), 791–799.
92. Vargas, M., Montero, C., Sanchez, D., Perez, D., Valdes, M., Alfonso, A., et al. Two initial vaccinations with the Bm86-based Gavacplus vaccine against Rhipicephalus (Boophilus) microplus induce similar reproductive suppression to three initial vaccinations under production conditions. BMC Vet. Res., 6, 2010, 43.
93. Vermij, P., USDA approves the first plant-based vaccine. Nat. Biotechnol. 24 (2006), 233–234.
94. Vézina, L.P., Faye, L., Lerouge, P., D'Aoust, M.A., Marquet-Blouin, E., Burel, C., et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol. J. 7 (2009), 442–455.
95. Virdi, V., Depicker, A., Role of plant expression systems in antibody production for passive immunization. Int. J. Dev. Biol. 57 (2013), 587–593.
96. Virdi, V., Coddens, A., De Buck, S., Millet, S., Goddeeris, B.M., Cox, E., et al. Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 11809–11814.
97. Wagner, B., Hufnagl, K., Radauer, C., Wagner, S., Baier, K., Scheiner, O., et al. Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant. J. Immunol. Methods 287 (2004), 203–215.
98. Wakasa, Y., Takagi, H., Hirose, S., Yang, L., Saeki, M., Nishimura, T., et al. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis. Plant Biotechnol. J. 11 (2013), 66–76.
99. Whitehead, M., Ohlschlager, P., Almajhdi, F.N., Alloza, L., Marzabal, P., Meyers, A.E., et al. Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice. BMC Cancer, 14, 2014, 367.
100. Wieland, W.H., Lammers, A., Schots, A., Orzaez, D.V., Plant expression of chicken secretory antibodies derived from combinatorial libraries. J. Biotechnol. 122 (2006), 382–391.
101. Wilken, L.R., Nikolov, Z.L., Recovery and purification of plant-made recombinant proteins. Biotechnol. Adv. 30 (2012), 419–433.
102. World Health Organization, The evolving threat of antimicrobial resistance: options for action. http://whqlibdoc.who.int/publications/2012/9789241503181_eng.pdf < accessed 2015/09/14 >, 2012.
103. Wu, H., Singh, N.K., Locy, R.D., Scissum-Gunn, K., Giambrone, J.J., Immunization of chickens with VP2 protein of infectious bursal disease virus expressed in Arabidopsis thaliana. Avian Dis. 48 (2004), 663–668.
104. Xiao, Y., Kwon, K.C., Hoffman, B.E., Kamesh, A., Jones, N.T., Herzog, R.W., et al. Low cost delivery of proteins bioencapsulated in plant cells to human non-immune or immune modulatory cells. Biomaterials 80 (2015), 68–79.
105. Yang, C.D., Liao, J.T., Lai, C.Y., Jong, M.H., Liang, C.M., Lin, Y.L., et al. Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes. BMC Biotechnol., 7, 2007, 62.
106. Yang, Z., Drew, D.P., Jorgensen, B., Mandel, U., Bach, S.S., Ulvskov, P., et al. Engineering mammalian mucin-type O-glycosylation in plants. J. Biol. Chem. 287 (2012), 11911–11923.
107. Yekta, M.A., Goddeeris, B.M., Vanrompay, D., Cox, E., Immunization of sheep with a combination of intimingamma, EspA and EspB decreases Escherichia coli O157:H7 shedding. Vet. Immunol. Immunopathol. 140 (2011), 42–46.
108. Yin, G., Lin, Q., Wei, W., Qin, M., Liu, X., Suo, X., et al. Protective immunity against Eimeria tenella infection in chickens induced by immunization with a recombinant C-terminal derivative of EtIMP1. Vet. Immunol. Immunopathol. 162 (2014), 117–121.
109. Yin, G., Lin, Q., Qiu, J., Qin, M., Tang, X., Suo, X., et al. Immunogenicity and protective efficacy of an Eimeria vaccine candidate based on Eimeria tenella immune mapped protein 1 and chicken CD40 ligand. Vet. Parasitol. 210 (2015), 19–24.
110. Yokoyama, H., Peralta, R.C., Diaz, R., Sendo, S., Ikemori, Y., Kodama, Y., Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets. Infect. Immun. 60 (1992), 998–1007.
111. Yusibov, V., Streatfield, S.J., Kushnir, N., Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum. Vaccin. 7 (2011), 313–321.
112. Zhai, Y., Zhong, Z., Zariffard, M., Spear, G.T., Qiao, L., Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies. Vaccine 31 (2013), 5422–5429.
113. Zhou, J.Y., Cheng, L.Q., Zheng, X.J., Wu, J.X., Shang, S.B., Wang, J.Y., et al. Generation of the transgenic potato expressing full-length spike protein of infectious bronchitis virus. J. Biotechnol. 111 (2004), 121–130.
114. Zimmermann, J., Saalbach, I., Jahn, D., Giersberg, M., Haehnel, S., Wedel, J., et al. Antibody expressing pea seeds as fodder for prevention of gastrointestinal parasitic infections in chickens. BMC Biotechnol., 9, 2009, 79.